Key result
Nebivolol showed no pharmacokinetic interactions when coadministered with hydrochlorothiazide, furosemide, ramipril, losartan, digoxin, or warfarin, though fluoxetine impeded its clearance.
Why the study?
Does coadministration of common cardiovascular drugs or fluoxetine affect the pharmacokinetics of nebivolol in poor and extensive CYP2D6 metabolizers?
Population
Subjects classified as poor CYP2D6 metabolizers and extensive CYP2D6 metabolizers
Authors
Loading...
May support coadministration without PK adjustment; leaves open clinical outcome confirmation in CYP2D6 subgroups.
Does coadministration of common cardiovascular drugs or fluoxetine affect the pharmacokinetics of nebivolol in poor and extensive CYP2D6 metabolizers?
Nebivolol can be safely coadministered with common cardiovascular medications without significant pharmacokinetic interactions, though fluoxetine may reduce its clearance in extensive CYP2D6 metabolizers.
Lindamood et al. (2010) studied Hypertension. Nebivolol coadministered with other drugs was evaluated on Drug-drug interactions (pharmacokinetics and clearance). Nebivolol showed no pharmacokinetic interactions when coadministered with hydrochlorothiazide, furosemide, ramipril, losartan, digoxin, or warfarin, though fluoxetine impeded its clearance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: